10-KThe Record
Damora Therapeutics, Inc. files 10-K
Filed Mar 9, 2023 · 3y ago · Accession 0000950170-23-006807
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 10-K
- Filing date
- Mar 9, 2023
- Report date
- Dec 31, 2022
- Document
- glto-20221231.htm
- Size
- 11.3 MB